WERA Drug Patent Profile
✉ Email this page to a colleague
When do Wera patents expire, and what generic alternatives are available?
Wera is a drug marketed by Novast Labs Ltd and is included in one NDA.
The generic ingredient in WERA is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for WERA?
- What are the global sales for WERA?
- What is Average Wholesale Price for WERA?
Summary for WERA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for WERA |
DailyMed Link: | WERA at DailyMed |
![WERA drug patent expirations Drug patent expirations by year for WERA](/p/graph/s/t/WERA-patent-expirations.png)
![Drug Prices for WERA](/p/graph/drug-price/WERA.png)
![Drug Sales Revenue Trends for WERA](/p/graph/drug-sales-revenues/WERA.png)
US Patents and Regulatory Information for WERA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novast Labs Ltd | WERA | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 091204-001 | Mar 27, 2012 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |